EXCLUSIVE: Alzheimer s Research UK chief executive Hilary Evans shared her vision for a future in which dementia is no longer the most feared condition of old age, and instead something we treat and live with.
The ALBORADA Drug Discovery Institute (ADDI) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.
The ALBORADA Drug Discovery Institute (ADDI) today (Tuesday 8 November) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.
The Rainwater Charitable Foundation announces partnership with drug discovery teams at the University of Oxford streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.